WHO ICTRP trial
Safety, tolerance and pharmacokinetics study of MN-08 tablet in Chinese healthy…
ChiCTR2000031414 · Chinese Clinical Trial Registry (ChiCTR) · Recruiting
Key facts
| Trial ID | ChiCTR2000031414 |
|---|---|
| Public title | Safety, tolerance and pharmacokinetics study of MN-08 tablet in Chinese healthy subjects |
| Scientific title | Safety, tolerance and pharmacokinetics study of MN-08 tablet in Chinese healthy subjects |
| Primary sponsor | Yanbian University Affiliated Hospital (yanbian Hospital) |
| Registry | Chinese Clinical Trial Registry (ChiCTR) |
| Recruitment status | Recruiting |
| Study type | Interventional study |
| Phase | 1 |
| Countries | China |
| Conditions | Idiopathic Pulmonary Arterial Hypertension |
| Interventions | 1:6 mg MN-08 tablets;2:12 mg MN-08 tablets;3:24 mg MN-08 tablets;4:42 mg MN-08 tablets;5:60 mg MN-08 tablets;6:84 mg MN-08 tablets;7:low-dose MN-08;8:middle-dose MN-08;9:high-dose MN-08 |
| Registration date | Mar 30, 2020 |
| Target size | 1:10;2:18;3:10;4:10;5:10;6:8;7:10;8:10;9:10 |
| Registry page | chictr.org.cn |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: